Ocular Surface Disease: Etiologies and Treatment Modalities
Webcast
1 AMA PRA Category 1 Credit™ Faculty
OVERVIEW
Ocular Surface Disease: Etiologies and Treatment Modalities is organized by Evolve Medical Education (EME) LLC.
Release Date: Feb 22, 2021
Expiration Date: Jan 31, 2024
Description:
Nearly 33% of patients in eye care clinics present with complaints about dry eye signs and symptoms. Clinicians remain challenged with both the diagnosis and best treatment options for dry eye disease (DED) because, to date, multiple causes of the disorder have been identified. This activity will help to inform clinicians on methods to improve the care of patients with DED.
Learning Objectives:
Upon completion of this activity, the participant should be able to:
- Differentiate between DED and meibomian gland dysfunction (MGD) and summarize the risk factors for DED and MGD.
- Explain the role of inflammatory processes in these diseases.
- Recognize the signs and symptoms in patients with ocular surface complaints.
- Appraise the differences between traditional and new diagnostic tests for DED and MGD.
- Compare the newest treatments for DED and MGD with first-generation treatments indicated for those conditions.
ACCREDITATION & CREDITS
Accreditation and Designation Statement:
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
TARGET AUDIENCE
PhysicianOptometristSPECIALITIES
Medical EducationOptometryOphthalmology
Quick Links